|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-3-30
|
|
pubmed:abstractText |
Induction immunosuppression utilizing lymphocytolytic agents in the early peri-operative period has a number of theoretical and practical advantages and disadvantages. However, the efficacy of cytolytic agents as induction therapy remains unproven.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1053-2498
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
392-400
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15797738-Adult,
pubmed-meshheading:15797738-Aged,
pubmed-meshheading:15797738-Antilymphocyte Serum,
pubmed-meshheading:15797738-Decision Making,
pubmed-meshheading:15797738-Follow-Up Studies,
pubmed-meshheading:15797738-Graft Rejection,
pubmed-meshheading:15797738-HLA Antigens,
pubmed-meshheading:15797738-Heart Transplantation,
pubmed-meshheading:15797738-Humans,
pubmed-meshheading:15797738-Immunosuppression,
pubmed-meshheading:15797738-Immunosuppressive Agents,
pubmed-meshheading:15797738-Middle Aged,
pubmed-meshheading:15797738-Multivariate Analysis,
pubmed-meshheading:15797738-Muromonab-CD3,
pubmed-meshheading:15797738-North America,
pubmed-meshheading:15797738-Perioperative Care,
pubmed-meshheading:15797738-Retrospective Studies,
pubmed-meshheading:15797738-Risk Factors,
pubmed-meshheading:15797738-Severity of Illness Index,
pubmed-meshheading:15797738-Survival Rate,
pubmed-meshheading:15797738-T-Lymphocytes
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
|
|
pubmed:affiliation |
University of Alabama at Birmingham, Division of Cardiothoracic Surgery, Birmingham, Alabama 35294, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|
